Mutations in the RAS-RAF-MEK-cascade, among which BRAF-mutations, induce EMT by allowing downstream effectors to promote the expression of transcription factor regulating EMT, leading to a mesenchymal phenotype of the tumour (Fridman et al. 2020; Janda et al. 2002). The gene discussed is BRAF; the disease is neoplasm.